prostate-specific membrane antigen

You have access
PSMA-Targeted Therapeutics: A Tale About Law and Economics
Johannes Notni

Journal of Nuclear Medicine March 31, 2021, jnumed.121.262308; DOI: https://doi.org/10.2967/jnumed.121.262308
You have access
¹⁷⁷Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
Hsiou-Ting Kuo, Kuo-Shyan Lin, Zhengxing Zhang, Carlos F. Uribe, Helen Merkens, Chengcheng Zhang and François Bénard

Journal of Nuclear Medicine April 1, 2021, 62 (4) 521-527; DOI: https://doi.org/10.2967/jnumed.120.250738
You have access
Head to head comparison of ⁶⁸Ga-NGUL and ⁶⁸Ga-PSMA-11 in patients with metastatic prostate cancer: a prospective study
Minseok Suh, Hyung-Jun Im, Hyun Gee Ryoo, Keon Wook Kang, Jae Min Jeong, Sneha Prakash, Sanjana S Ballal, Madhav P Yadav, Chandrasekhar Bal, Chang Wook Jeong, Cheol Kwak and Gi Jeong Cheon

Journal of Nuclear Medicine March 26, 2021, jnumed.120.258434; DOI: https://doi.org/10.2967/jnumed.120.258434
Open Access
Head-to-head comparison of ⁶⁸Ga-prostate-specific membrane antigen PET/CT and ferumoxtran-10 enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients
Melline GM Schilham, Patrik Zamecnik, Bastiaan M Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O Barentsz, James Nagarajah and Martin Gotthardt

Journal of Nuclear Medicine January 30, 2021, jnumed.120.258541; DOI: https://doi.org/10.2967/jnumed.120.258541
You have access
The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study
Sara Harsini, Heather Saprunoff, Tina Alden, Behnoud Mohammadi, Don Wilson and François Bénard

Journal of Nuclear Medicine January 1, 2021, 62 (1) 81-87; DOI: https://doi.org/10.2967/jnumed.120.246983
You have access
Positive predictive value and correct detection rate of ¹⁸F-rhPSMA-7 PET in biochemically recurrent prostate cancer validated by composite reference standard
Maythinee Chantadisai, Gabriel Buschner, Markus Krönke, Isabel Rauscher, Thomas Langbein, Stephan G. Nekolla, Kilian Schiller, Matthias M. Heck, Tobias Maurer, Alexander Wurzer, Hans-Juergen Wester, Calogero D'Alessandria, Wolfgang Weber and Matthias Eiber

Journal of Nuclear Medicine November 27, 2020, jnumed.120.255661; DOI: https://doi.org/10.2967/jnumed.120.255661
You have access
Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Study
Thorsten Derlin, Rudolf A. Werner, Marcel Lafos, Christoph Henkenberens, Christoph A.J. von Klot, Jan M. Sommerlath Sohns, Tobias L. Ross and Frank M. Bengel

Journal of Nuclear Medicine November 1, 2020, 61 (11) 1602-1606; DOI: https://doi.org/10.2967/jnumed.120.241588
You have access
Early Prostate-Specific Antigen Changes and Clinical Outcome After ¹⁷⁷Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer
Andrei Gafita, Matthias M. Heck, Isabel Rauscher, Robert Tauber, Lisena Cala, Charlott Franz, Calogero D’Alessandria, Margitta Retz, Wolfgang A. Weber and Matthias Eiber

Journal of Nuclear Medicine October 1, 2020, 61 (10) 1476-1483; DOI: https://doi.org/10.2967/jnumed.119.240242
You have access
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of ¹⁷⁷Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, Justin Ferdinandus, Sue-Ping Thang, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, David Pattison, Alexis Beaulieu, Jennifer Mooi, Ben Tran, Christina Guo, Victor Kalff, Declan G Murphy, Price Jackson, Peter Eu, Mark Scalzo, Scott Williams, Rodney J. Hicks and Michael S. Hofman

Journal of Nuclear Medicine June 1, 2020, 61 (6) 857-865; DOI: https://doi.org/10.2967/jnumed.119.236414
You have access
3-Year Freedom from Progression After ⁶⁸Ga-PSMA PET/CT–Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial
Louise Emmett, Reuben Tang, Rohan Nandurkar, George Hruby, Paul Roach, Jo Anne Watts, Thomas Cusick, Andrew Kneebone, Bao Ho, Lyn Chan, Pim J. van Leeuwen, Matthijs J. Scheltema, Andrew Nguyen, Charlotte Yin, Andrew Scott, Colin Tang, Michael McCarthy, Karen Fullard, Matthew Roberts, Roslyn Francis and Phillip Stricker

Journal of Nuclear Medicine June 1, 2020, 61 (6) 866-872; DOI: https://doi.org/10.2967/jnumed.119.235028

Main menu

User menu

Search

prostate-specific membrane antigen

Pages